Rock Springs Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Rock Springs Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-255,500	Closed	-$29.6M	–	124
2023 Q3	$29.6M	Sell	255,500 -239,500	-48%	-$25.7M	0.79%	41
2023 Q2	$50.9M	Sell	495,000 -245,100	-33%	-$25.9M	1.21%	28
2023 Q1	$80.8M	Buy	740,100 +400	+0.1%	+$44.2K	1.93%	17
2022 Q4	$84.2M	Buy	739,700 +12,700	+2%	+$1.05M	2.03%	13
2022 Q3	$45M	Sell	727,000 -19,000	-3%	-$1.33M	1.16%	27
2022 Q2	$59.5M	Hold	746,000	–	–	1.73%	15
2022 Q1	$78.5M	Hold	746,000	–	–	1.98%	11
2021 Q4	$80.4M	Buy	746,000 +44,000	+6%	+$4.8M	1.86%	14
2021 Q3	$76.9M	Buy	702,000 +77,000	+12%	+$7.99M	1.62%	16
2021 Q2	$58.5M	Hold	625,000	–	–	1.16%	26
2021 Q1	$57.5M	Hold	625,000	–	–	1.26%	25
2020 Q4	$45.7M	Sell	625,000 -25,000	-4%	-$1.86M	0.97%	33
2020 Q3	$50.5M	Buy	+650,000	New	+$44.7M	1.28%	23

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Rock Springs Capital Management's HZNP Position: Q4 2023 in Review

Rock Springs Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 255,500 shares — an estimated $29.6M sold.

Rock Springs Capital Management first reported a position in HZNP in Q3 2020 and held it in 13 quarters. The position peaked at $84.2M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Rock Springs Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Rock Springs Capital Management sold 255,500 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $29.6M.
Rock Springs Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 13 quarters.
Rock Springs Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $84.2M in Q4 2022.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Rock Springs Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.